Effect of losartan versus afenolol on aortic valve sclerosis (a LIFE substudy)OLSEN, Michael H; WACHTELL, Kristian; DEVEREUX, Richard B et al.The American journal of cardiology. 2004, Vol 94, Num 8, pp 1076-1080, issn 0002-9149, 5 p.Article

Low-affinity state betal-adrenoceptor-induced vasodilation in SHRMOHAMED YASSINE MALLEM; RECULEAU, Olivier; LE COZ, Olivier et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 8, pp 1463-1467, issn 0196-9781, 5 p.Conference Paper

A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked ratsLOH, K. P; LOW, L. S; WONG, W. H et al.Neuroscience letters. 2006, Vol 398, Num 1-2, pp 28-33, issn 0304-3940, 6 p.Article

Angiotensin II can induce and potentiate shape change in human platelets : effect of losartanJAGROOP, I. A; MIKHAILIDIS, D. P.Journal of human hypertension. 2000, Vol 14, Num 9, pp 581-585, issn 0950-9240Article

Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injuryMOON, Michael C; MOLNAR, Katerina; YAU, Lorraine et al.Journal of vascular surgery. 2004, Vol 40, Num 1, pp 130-137, issn 0741-5214, 8 p.Article

Losartan : a study of pharmacovigilance data on 14 522 datientsMANN, R. D; MACKAY, F; PEARCE, G et al.Journal of human hypertension. 1999, Vol 13, Num 8, pp 551-557, issn 0950-9240Article

Losartan-associated atypical cutaneous lymphoid hyperplasiaVIRABEN, R; LAMANT, L; BROUSSET, P et al.Lancet (British edition). 1997, Vol 350, Num 9088, issn 0140-6736, p. 1366Article

Effects of AT1 receptor antagonist losartan on sICAM-1 and TNF-α levels in uncomplicated hypertensive patientsSARDO, Maria A; CASTALDO, Maria; CINQUEGRANI, Maurizio et al.Angiology. 2004, Vol 55, Num 2, pp 195-203, issn 0003-3197, 9 p.Article

Pancreatitis after losartanBIRCK, R; KEIM, V; FIEDLER, F et al.Lancet (British edition). 1998, Vol 351, Num 9110, issn 0140-6736, p. 1178Article

Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosisDUCLOUX, D; FOURNIER, V; BRESSON-VAUTRIN, C et al.Transplant international. 1998, Vol 11, Num 4, pp 312-315, issn 0934-0874Article

Angiotensin II antagonistsSMITH, R. D; CUNNINGHAM, G; KIVLIGHN, S. D et al.Emerging drugs. 1998, Vol 3, pp 81-93, issn 1361-9195Article

Effect of losartan on human platelet activationGUERRA-CUESTA, J. I; MONTON, M; LOPEZ-FARRE, A et al.Journal of hypertension. 1999, Vol 17, Num 3, pp 447-452, issn 0263-6352Article

Losartan blocks the excitatory effect of peripheral hypertonic stimulation on vasopressinergic neurons in hypothalamic paraventricular nucleus in rats : electrophysiological and immunocytochemical evidenceQI ZHU; GUO, Shi-Yu; SHAN GONG et al.Neuroscience letters. 2005, Vol 380, Num 1-2, pp 12-16, issn 0304-3940, 5 p.Article

Inhibiteurs des récepteurs AT1 à l'angiotensine II = Inhibitors of angiotensin II AT1 receptorsBOUTOUYRIE, P.STV. Sang thrombose vaisseaux. 1999, Vol 11, Num 6, pp 479-484, issn 0999-7385Article

Pharma-clinics. Le médicament du mois : Le losartan (Cozaar®) = Losartan:drug of the monthSCHEEN, A. J.RMLG. Revue médicale de Liège. 1997, Vol 52, Num 5, pp 367-369, issn 0370-629XArticle

Pharmacokinetic- pharmacodynamic interactions of candesartan cilexetil and losartanAZIZI, M; CHATELLIER, G; GUYENE, T.-T et al.Journal of hypertension. 1999, Vol 17, Num 4, pp 561-568, issn 0263-6352Article

Solubilities of losartan polymorphsCROCKER, L. S; MCCAULEY, J. A.Pharmazie. 1997, Vol 52, Num 1, issn 0031-7144, p. 72Article

Inhibition of angiotensin II pressor response and ex vivo angiotensin II radioligand binding by candesartan cilexetil and losartan in healthy human volunteersBELZ, G. G; FUCHS, B; MALERCZYK, C et al.Journal of human hypertension. 1997, Vol 11, pp S45-S47, issn 0950-9240, SUP2Article

A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinityARSENAULT, Jason; LEHOUX, Julie; LANTHIER, Luc et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 6, pp 377-388, issn 1744-6872, 12 p.Article

Measuring Angiotensin-I Converting Enzyme Inhibitory Activity by Micro Plate Assays: Comparison Using Marine Cryptides and Tentative Threshold Determinations with Captopril and LosartanBEN HENDA, Yesmine; LABIDI, Anis; ARNAUDIN, Ingrid et al.Journal of agricultural and food chemistry (Print). 2013, Vol 61, Num 45, pp 10685-10690, issn 0021-8561, 6 p.Article

CORD: Comparison of Recommended Doses of ace inhibitors and angiotensin II receptor blockersSPINAR, J; VITOVEC, J; SOUCEK, M et al.International journal of cardiology. 2010, Vol 144, Num 2, pp 293-294, issn 0167-5273, 2 p.Article

Renal nitric oxide production is decreased in diabetic rats and improved by AT₁ receptor blockadeAWAD, Alaa S; WEBB, Randy L; CAREY, Robert M et al.Journal of hypertension. 2004, Vol 22, Num 8, pp 1571-1577, issn 0263-6352, 7 p.Article

Role of angiotensin II in the brain inflammatory events during experimental diabetes in ratsVARGAS, Renata; RINCON, Jaimar; PEDREANEZ, Adriana et al.Brain research. 2012, Vol 1453, pp 64-76, issn 0006-8993, 13 p.Article

The effects of losartan on signal-averaged P wave in patients with atrial fibrillationNOMURA, Masahiro; KAWANO, Tomohito; NAKAYASU, Kimiko et al.International journal of cardiology. 2008, Vol 126, Num 1, pp 21-27, issn 0167-5273, 7 p.Article

Intracerebroventricular injection of losartan inhibits angiotensin II-sensitive neurons via GABA inputs in the anterior hypothalamic area of ratsHAGIWARA, Yukihiko; KUBO, Takao.Neuroscience letters. 2007, Vol 416, Num 2, pp 150-154, issn 0304-3940, 5 p.Article